Join top executives in San Francisco on July 11-12, to hear how leaders are integrating and optimizing AI investments for success. Learn More

Korean companies are reaching out beyond the mobile realm. That fact is evidenced by the $3.5 million in Series A funding raised by Ybrain today, which will be used to build new products and expand the company’s internal team.

The health care wearables startup has clinical trials in the works for various neurological disorders. The Ybrain is actually a wearable that’s brain signal-based. It’s currently working on a big data platform that compiles brain signal data collected from its devices. Ybrain plans to use this data to provide more intuitive and personalized treatments — as well as to specialize in creating products for patients with Alzheimer’s disease.

Stonebridge Capital led the round, bringing the total capital raised by Ybrain to $4.2 million. It previously raised $643,000 in a seed funding round from an undisclosed investor.

The Seoul-based company was founded in February 2013 and is led by CEO Kyongsik Yun, a Caltech neuroscientist. The team is also made up of engineers from Samsung.

The Ybrain device may call to mind a previous wearable covered here at VentureBeat, the Muse, a headband that senses brain signals to aid wearers in neurofeedback, meditation, controlling devices with thought, and more. And just two days ago, we featured a sponsored post from Mobile Programming all about the profound power that health care wearables hold in store.

VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Discover our Briefings.